Frontage Holdings Corporation (FGHQF)

Market Cap	267.17M -38.4%
Revenue (ttm)	253.01M -2.7%
Net Income	3.84M -37.1%
EPS	0.00 -35.4%
Shares Out	n/a
PE Ratio	69.67
Forward PE	15.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,000
Average Volume	86,705
Open	0.1400
Previous Close	n/a
Day's Range	0.1400 - 0.1400
52-Week Range	0.1400 - 0.1498
Beta	0.30
RSI	n/a
Earnings Date	Mar 27, 2026

About Frontage Holdings

Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies. It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening. The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early phase clinical services; and bioequivalence and related services, such as pharmacology, medical writing, an...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Employees: 1,540
• Stock Exchange: OTCMKTS
• Ticker Symbol: FGHQF

Financial Performance

In 2024, Frontage Holdings's revenue was $254.91 million, a decrease of -1.90% compared to the previous year's $259.86 million. Earnings were $791,000, a decrease of -92.68%.